¥3.75   ( %)
前日收盘: 当日成交量(股): 当日最高: 总股本:2580.46万
当日开盘: 当日成交额(元): 当日最低: 流通股本:
市盈率(动/静):0/0 市净率:0 市销率:0 总市值:9676.73万
52周最高:12.90 52周最低:1.79 转让方式: 单位:美元
$Evofem(EVFM)$
  • 还可以输入
  • 20016

Evofem(EVFM) 09月18日 23时17分

新闻 Evofem Biosciences to Present at Upcoming Investor Conferences
SAN DIEGO, Sept. 18, 2018 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ:EVFM) ("Evofem" or the "Company&qu ......  url.vc.watch/Jsop
查看全文

Evofem(EVFM) 09月11日 16时16分

公告 Evofem Biosciences, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Fitzpatrick Alexander A
公告日:2018-08-21, 内部交易人:Fitzpatrick Alexander A, 与发行人关系:General Counsel and Secretary/高管/, 操作:买入,5000(股)Common Stock,均价$2.2070; 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-08-20, SEC Accession No. 0001618835-18-000090, File:https://www.sec.gov/Archives/edgar/data/1618835/000161883518000090/0001618835-18-000090-index.htm $Evofem(EVFM)$
查看全文

Evofem(EVFM) 09月11日 16时16分

公告 Evofem Biosciences, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Culwell Kelly
公告日:2018-08-20, 内部交易人:Culwell Kelly, 与发行人关系:Chief Medical Officer/高管/, 操作:买入,3000(股)Common Stock,均价$2.2400; 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-08-16, SEC Accession No. 0001618835-18-000088, File:https://www.sec.gov/Archives/edgar/data/1618835/000161883518000088/0001618835-18-000088-index.htm $Evofem(EVFM)$
查看全文

Evofem(EVFM) 09月11日 16时16分

公告 Evofem Biosciences, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Lynch Thomas G
公告日:2018-08-15, 内部交易人:Lynch Thomas G, 与发行人关系:/董事/, 操作:买入,100000(股)Common Stock,均价$2.2585; 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-08-14, SEC Accession No. 0001618835-18-000086, File:https://www.sec.gov/Archives/edgar/data/1618835/000161883518000086/0001618835-18-000086-index.htm $Evofem(EVFM)$
查看全文

Evofem(EVFM) 09月11日 16时15分

公告 Evofem Biosciences, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Barrans Russell
公告日:2018-08-13, 内部交易人:Barrans Russell, 与发行人关系:Chief Commercial Officer/高管/, 操作:买入,3715(股)Common Stock,均价$1.9800; 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-08-10, SEC Accession No. 0001618835-18-000084, File:https://www.sec.gov/Archives/edgar/data/1618835/000161883518000084/0001618835-18-000084-index.htm $Evofem(EVFM)$
查看全文

Evofem(EVFM) 09月11日 16时15分

公告 Evofem Biosciences, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:PELLETIER SAUNDRA L
公告日:2018-08-13, 内部交易人:PELLETIER SAUNDRA L, 与发行人关系:Chief Executive Officer/董事/高管/, 操作:买入,10000(股)Common Stock,均价$2.1100; 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-08-10, SEC Accession No. 0001618835-18-000083, File:https://www.sec.gov/Archives/edgar/data/1618835/000161883518000083/0001618835-18-000083-index.htm $Evofem(EVFM)$
查看全文

Evofem(EVFM) 09月11日 16时15分

Evofem(EVFM) 08月24日 00时31分

新闻 Evofem Biosciences to Present at 20th Annual Global Investment Conference on September 6, 2018
SAN DIEGO, Aug. 23, 2018 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ:EVFM) ("Evofe ......  url.vc.watch/jE9e
查看全文

Evofem(EVFM) 08月16日 00时58分

新闻 Evofem Biosciences Reports Second Quarter 2018 Financial Results and Provides Corporate Update
Phase 3 Trial of Amphora for Hormone-free Contraception Continues to Move Ahead of Schedule; To ......  url.vc.watch/jLiD
查看全文

Evofem(EVFM) 08月16日 00时58分

新闻 Evofem Biosciences' Chief Medical Officer, Dr. Kelly Culwell, to Present at #BlogHer18 Creators Summit SAN DIEGO, Aug. 7, 2018 /PRNewswire/ -- Evofem Biosciences, I ......  url.vc.watch/jLiw
查看全文

Evofem(EVFM) 08月03日 11时07分

公告 Evofem Biosciences, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Rutherford Colin
公告日:2018-08-02, 内部交易人:Rutherford Colin, 与发行人关系:/董事/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-07-31, SEC Accession No. 0001618835-18-000080, File:https://www.sec.gov/Archives/edgar/data/1618835/000161883518000080/0001618835-18-000080-index.htm $Evofem(EVFM)$
查看全文

Evofem(EVFM) 08月03日 11时07分

公告 Evofem Biosciences, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:File Justin J.
公告日:2018-08-02, 内部交易人:File Justin J., 与发行人关系:Chief Financial Officer/高管/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-07-31, SEC Accession No. 0001618835-18-000079, File:https://www.sec.gov/Archives/edgar/data/1618835/000161883518000079/0001618835-18-000079-index.htm $Evofem(EVFM)$
查看全文

Evofem(EVFM) 08月03日 11时07分

公告 Evofem Biosciences, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Barrans Russell
公告日:2018-08-02, 内部交易人:Barrans Russell, 与发行人关系:Chief Commercial Officer/高管/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-07-31, SEC Accession No. 0001618835-18-000078, File:https://www.sec.gov/Archives/edgar/data/1618835/000161883518000078/0001618835-18-000078-index.htm $Evofem(EVFM)$
查看全文

Evofem(EVFM) 08月03日 11时07分

公告 Evofem Biosciences, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Fitzpatrick Alexander A
公告日:2018-08-02, 内部交易人:Fitzpatrick Alexander A, 与发行人关系:General Counsel and Secretary/高管/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-07-31, SEC Accession No. 0001618835-18-000077, File:https://www.sec.gov/Archives/edgar/data/1618835/000161883518000077/0001618835-18-000077-index.htm $Evofem(EVFM)$
查看全文

Evofem(EVFM) 08月03日 11时07分

公告 Evofem Biosciences, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Lynch Thomas G
公告日:2018-08-02, 内部交易人:Lynch Thomas G, 与发行人关系:/董事/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-07-31, SEC Accession No. 0001618835-18-000076, File:https://www.sec.gov/Archives/edgar/data/1618835/000161883518000076/0001618835-18-000076-index.htm $Evofem(EVFM)$
查看全文

Evofem(EVFM) 08月03日 11时07分

公告 Evofem Biosciences, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:PELLETIER SAUNDRA L
公告日:2018-08-02, 内部交易人:PELLETIER SAUNDRA L, 与发行人关系:Chief Executive Officer/董事/高管/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-07-31, SEC Accession No. 0001618835-18-000075, File:https://www.sec.gov/Archives/edgar/data/1618835/000161883518000075/0001618835-18-000075-index.htm $Evofem(EVFM)$
查看全文

Evofem(EVFM) 08月03日 11时07分

公告 Evofem Biosciences, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Culwell Kelly
公告日:2018-08-02, 内部交易人:Culwell Kelly, 与发行人关系:Chief Medical Officer/高管/, 本次交易含有相关衍生证券(puts, calls, warrants, options, convertible securities)的交易; 报告日:2018-07-31, SEC Accession No. 0001618835-18-000074, File:https://www.sec.gov/Archives/edgar/data/1618835/000161883518000074/0001618835-18-000074-index.htm $Evofem(EVFM)$
查看全文

Evofem(EVFM) 08月03日 11时07分

查看全文

Evofem(EVFM) 08月02日 20时11分

Evofem(EVFM) 08月02日 18时39分

查看全文
  • 首页 上一页 1 2 下一页 尾页  每页20条/共36